Selective, silent antagonist of a putative endothelial anandamide receptor distinct from CB1
receptors. Inhibits vasodilation and cell migration induced by abnormal-cannabidiol
(abn-CBD; Cat. No. 1297).
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Sold under license from the NIH, US patent 60/312,674
Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor.
Offert?ler et al.
Atypical cannabinoid stimulates endothelial cell migration via a Gi/Go coupled receptor distinct from CB1, CB2 or EDG-1.
Mo et al.
Vasorelaxant effects of oleamide in rat small mesenteric artery indicate action at a novel cannabinoid receptor.
Hoi and Hiley